Skip to main content

Manufacturing reliable healthcare solutions
to improve people’s lives

A brand that the world can rely on

We have mastered core manufacturing processes over the years, allowing us to provide novel and efficient products to people in various global markets. Our collective manufacturing expertise gives us the leverage to develop reliable medicines of excellent quality.

Group manufacturing expertise

Contract research services
for developing generic drugs

We provide high-quality and safe generic drugs to more than 40 countries across major continents, made possible by our rapid generic drug development and competent contract research services.

A streamlined approach
to commercial manufacturing

We implement a distinct and smooth process that entails intensive R&D, well-structured scaling up, contract manufacturing to enhance overall productivity, and rigorous clinical trials for ensuring safety evaluation. All these steps ultimately lead to reliable commercial manufacturing.

Analytical method development and validation

In order to critically evaluate product-specific acceptance criteria and achieve accurate results, we implement the analytical method of drug development followed by the required validation procedures.

ANDA filing

We identify product potential, enabling us to devise innovative process solutions. After this, we proceed with product approvals, eventually leading to an ANDA filing with the FDA.

IP formulations and process technology

We have developed financially-prudent high-efficiency methods to innovate IP-oriented formulations. We also economize the development of process technologies.

Experienced regulatory team

All through the development process, our knowledgeable regulatory teams conduct periodic quality checks to ensure that our complex generics are highly efficacious. Strong API manufacturers support our formulation development, ensuring that our medicinal supply remains stable and consistent for the foreseeable future.

Manufacturing expertise at our world-class facilities

USA plant

Our ultra-modern manufacturing facility in the USA is dedicated to manufacturing oral solids such as tablets and capsules.

Accreditations

UNIT I: ORAL SOLIDS

DOSAGE FORMS
QUANTITY/MONTH
Tablets
40 million
Capsules
35 million

India plant

Our advanced state-of-the-art manufacturing facility in India has a massive production capacity. Our team of experts meticulously operates the manufacturing process of Small Volume Parenterals, Oral Solids and Liquids, Beta-Lactam, and Cephalosporins (SVP), which are produced in millions every month.

UNIT II: SMALL VOLUME PARENTERALS

DOSAGE FORMS
QUANTITY/MONTH
Ampoules
2 million
Liquid Vials
2 million
Dry Powder Vials
1.25 million
Lyophilized Vials
0.2 million

UNIT III: ORAL SOLIDS & LIQUIDS

DOSAGE FORMS
QUANTITY/MONTH
Tablets
62.5 million
Capsules
12.5 million
Dry Powder
0.50 million
Oral Liquid
0.625 million

UNIT IV: BETA-LACTAM, ORAL SOLIDS & LIQUIDS

DOSAGE FORMS
QUANTITY/MONTH
Tablets
5 million
Capsules
12.5 million
Dry Powder
5 million

UNIT V: CEPHALOSPORINS SVP

DOSAGE FORMS
QUANTITY/MONTH
Ampoules
2 million
Liquid Vials
2 million

Accreditations